01:59 PM EDT, 06/10/2025 (MT Newswires) -- Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index rising 1.6% and the Health Care Select Sector SPDR Fund (XLV) adding 1.3%.

The iShares Biotechnology ETF (IBB) climbed 1.4%.

In corporate news, Novo Nordisk ( NVO ) shares jumped past 6%. The company has launched a new late-stage trial to evaluate how well its experimental obesity drug CagriSema helps patients lose weight and maintain weight loss over the long term.

Eli Lilly ( LLY ) will only partner with telehealth firms that stop selling copycat versions of its weight-loss drug, Bloomberg reported, citing Chief Financial Officer Lucas Montarce, speaking at a conference. Eli Lilly ( LLY ) shares were rising 4%.

Insmed ( INSM ) shares surged 28% after the firm said its phase 2b trial of treprostinil palmitil inhalation powder in patients with pulmonary arterial hypertension met its primary endpoint and all secondary efficacy endpoints.

Monte Rosa Therapeutics ( GLUE ) shares popped 3.7% after it said the US Food and Drug Administration has accepted its investigational new drug application of MRT-8102 to treat some inflammatory diseases.